Compile Data Set for Download or QSAR

Found 309 hits with Last Name = 'austin' and Initial = 'ne'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410424 (CHEMBL199088) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4ccc(nc4)C(F)(F)F)c3cc12 Show InChI InChI=1S/C23H22F3N5O/c1-29-8-10-30(11-9-29)21-18-13-19-16(12-15(18)4-6-27-21)5-7-31(19)22(32)17-2-3-20(28-14-17)23(24,25)26/h2-4,6,12-14H,5,7-11H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	0.251	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1A (Homo sapiens (Human))	BDBM50410428 (CHEMBL380812) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4cnn5ccccc45)c3cc12 Show InChI InChI=1S/C24H24N6O/c1-27-10-12-28(13-11-27)23-19-15-22-18(14-17(19)5-7-25-23)6-9-29(22)24(31)20-16-26-30-8-3-2-4-21(20)30/h2-5,7-8,14-16H,6,9-13H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	0.316	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-5-HT or [3H]8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410426 (CHEMBL370852) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4ccc(Cl)cc4)c3cc12 Show InChI InChI=1S/C23H23ClN4O/c1-26-10-12-27(13-11-26)22-20-15-21-18(14-17(20)6-8-25-22)7-9-28(21)23(29)16-2-4-19(24)5-3-16/h2-6,8,14-15H,7,9-13H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.316	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1D (Homo sapiens (Human))	BDBM50410424 (CHEMBL199088) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4ccc(nc4)C(F)(F)F)c3cc12 Show InChI InChI=1S/C23H22F3N5O/c1-29-8-10-30(11-9-29)21-18-13-19-16(12-15(18)4-6-27-21)5-7-31(19)22(32)17-2-3-20(28-14-17)23(24,25)26/h2-4,6,12-14H,5,7-11H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	0.501	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410427 (CHEMBL194647) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4ccc(cc4)C#N)c3cc12 Show InChI InChI=1S/C24H23N5O/c1-27-10-12-28(13-11-27)23-21-15-22-20(14-19(21)6-8-26-23)7-9-29(22)24(30)18-4-2-17(16-25)3-5-18/h2-6,8,14-15H,7,9-13H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.501	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1D (Homo sapiens (Human))	BDBM50410426 (CHEMBL370852) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4ccc(Cl)cc4)c3cc12 Show InChI InChI=1S/C23H23ClN4O/c1-26-10-12-27(13-11-26)22-20-15-21-18(14-17(20)6-8-25-22)7-9-28(21)23(29)16-2-4-19(24)5-3-16/h2-6,8,14-15H,7,9-13H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.501	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1A (Homo sapiens (Human))	BDBM50410440 (CHEMBL198975) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4cnn(c4C)-c4ccccc4)c3cc12 Show InChI InChI=1S/C27H28N6O/c1-19-24(18-29-33(19)22-6-4-3-5-7-22)27(34)32-11-9-21-16-20-8-10-28-26(23(20)17-25(21)32)31-14-12-30(2)13-15-31/h3-8,10,16-18H,9,11-15H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.631	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-5-HT or [3H]8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410440 (CHEMBL198975) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4cnn(c4C)-c4ccccc4)c3cc12 Show InChI InChI=1S/C27H28N6O/c1-19-24(18-29-33(19)22-6-4-3-5-7-22)27(34)32-11-9-21-16-20-8-10-28-26(23(20)17-25(21)32)31-14-12-30(2)13-15-31/h3-8,10,16-18H,9,11-15H2,1-2H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.631	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1D (Homo sapiens (Human))	BDBM50410440 (CHEMBL198975) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4cnn(c4C)-c4ccccc4)c3cc12 Show InChI InChI=1S/C27H28N6O/c1-19-24(18-29-33(19)22-6-4-3-5-7-22)27(34)32-11-9-21-16-20-8-10-28-26(23(20)17-25(21)32)31-14-12-30(2)13-15-31/h3-8,10,16-18H,9,11-15H2,1-2H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.631	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1D (Homo sapiens (Human))	BDBM50410430 (CHEMBL372743) Show SMILES CCc1c(cnn1-c1ccc(cc1)C#N)C(=O)N1CCc2cc3ccnc(N4CCN(C)CC4)c3cc12 Show InChI InChI=1S/C29H29N7O/c1-3-26-25(19-32-36(26)23-6-4-20(18-30)5-7-23)29(37)35-11-9-22-16-21-8-10-31-28(24(21)17-27(22)35)34-14-12-33(2)13-15-34/h4-8,10,16-17,19H,3,9,11-15H2,1-2H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.631	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1A (Homo sapiens (Human))	BDBM50410426 (CHEMBL370852) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4ccc(Cl)cc4)c3cc12 Show InChI InChI=1S/C23H23ClN4O/c1-26-10-12-27(13-11-26)22-20-15-21-18(14-17(20)6-8-25-22)7-9-28(21)23(29)16-2-4-19(24)5-3-16/h2-6,8,14-15H,7,9-13H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.794	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-5-HT or [3H]8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1D (Homo sapiens (Human))	BDBM50410427 (CHEMBL194647) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4ccc(cc4)C#N)c3cc12 Show InChI InChI=1S/C24H23N5O/c1-27-10-12-28(13-11-27)23-21-15-22-20(14-19(21)6-8-26-23)7-9-29(22)24(30)18-4-2-17(16-25)3-5-18/h2-6,8,14-15H,7,9-13H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.794	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410437 (CHEMBL370625) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4cccc5ncccc45)c3cc12 Show InChI InChI=1S/C26H25N5O/c1-29-12-14-30(15-13-29)25-22-17-24-19(16-18(22)7-10-28-25)8-11-31(24)26(32)21-4-2-6-23-20(21)5-3-9-27-23/h2-7,9-10,16-17H,8,11-15H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.794	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474384 (CHEMBL2113364) Show SMILES Cl.CS(=O)(=O)Oc1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)\C=C\c3ccc(F)cc3)CCc2c1 |r,wU:15.13,wD:18.20,(23.3,.02,;-6.64,-.16,;-5.58,-.78,;-6.64,-1.39,;-5.57,.45,;-4.24,-1.55,;-2.91,-.78,;-2.91,.78,;-1.53,1.57,;,.78,;.8,1.73,;2.31,1.43,;3.02,,;4.56,.01,;5.33,1.34,;6.87,1.35,;7.63,2.69,;9.17,2.69,;9.95,1.36,;9.18,.02,;7.64,.02,;11.49,1.36,;12.26,.02,;11.64,-1.04,;13.8,.03,;14.57,-1.31,;16.11,-1.31,;16.88,.03,;18.42,.03,;19.19,-1.3,;20.42,-1.3,;18.43,-2.64,;16.89,-2.64,;2.29,-1.45,;.76,-1.7,;,-.78,;-1.53,-1.57,)| Show InChI InChI=1S/C28H35FN2O4S.ClH/c1-36(33,34)35-27-12-7-23-15-18-31(19-16-24(23)20-27)17-14-22-4-10-26(11-5-22)30-28(32)13-6-21-2-8-25(29)9-3-21;/h2-3,6-9,12-13,20,22,26H,4-5,10-11,14-19H2,1H3,(H,30,32);1H/b13-6+;/t22-,26-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	0.794	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410428 (CHEMBL380812) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4cnn5ccccc45)c3cc12 Show InChI InChI=1S/C24H24N6O/c1-27-10-12-28(13-11-27)23-19-15-22-18(14-17(19)5-7-25-23)6-9-29(22)24(31)20-16-26-30-8-3-2-4-21(20)30/h2-5,7-8,14-16H,6,9-13H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1A (Homo sapiens (Human))	BDBM50410427 (CHEMBL194647) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4ccc(cc4)C#N)c3cc12 Show InChI InChI=1S/C24H23N5O/c1-27-10-12-28(13-11-27)23-21-15-22-20(14-19(21)6-8-26-23)7-9-29(22)24(30)18-4-2-17(16-25)3-5-18/h2-6,8,14-15H,7,9-13H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-5-HT or [3H]8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474398 (CHEMBL2368629) Show SMILES Cl.CS(=O)(=O)c1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)\C=C\c3ccc(F)cc3)CCc2c1 |r,wU:17.19,wD:14.12,(18.31,,;-11.73,1.48,;-10.96,.14,;-12.29,-.63,;-10.19,-1.19,;-9.62,.91,;-9.62,2.45,;-8.29,3.22,;-6.96,2.45,;-5.75,3.41,;-4.25,3.07,;-3.58,1.68,;-2.04,1.68,;-1.27,.35,;.27,.35,;1.04,-.98,;2.58,-.98,;3.35,.35,;2.58,1.68,;1.04,1.68,;4.89,.35,;5.66,-.98,;4.89,-2.32,;7.2,-.98,;7.97,-2.32,;9.51,-2.32,;10.28,-3.65,;11.82,-3.65,;12.59,-2.32,;14.13,-2.32,;11.82,-.98,;10.28,-.98,;-4.25,.3,;-5.75,-.05,;-6.96,.91,;-8.29,.14,)| Show InChI InChI=1S/C28H35FN2O3S.ClH/c1-35(33,34)27-12-7-23-15-18-31(19-16-24(23)20-27)17-14-22-4-10-26(11-5-22)30-28(32)13-6-21-2-8-25(29)9-3-21;/h2-3,6-9,12-13,20,22,26H,4-5,10-11,14-19H2,1H3,(H,30,32);1H/b13-6+;/t22-,26-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1D (Homo sapiens (Human))	BDBM50410432 (CHEMBL197947) Show SMILES CCc1c(cnn1-c1ccc(cc1)C#N)C(=O)N1CCc2cc3ccnc(N4CCN5CCC[C@@H]5C4)c3cc12 Show InChI InChI=1S/C31H31N7O/c1-2-28-27(19-34-38(28)24-7-5-21(18-32)6-8-24)31(39)37-13-10-23-16-22-9-11-33-30(26(22)17-29(23)37)36-15-14-35-12-3-4-25(35)20-36/h5-9,11,16-17,19,25H,2-4,10,12-15,20H2,1H3/t25-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410430 (CHEMBL372743) Show SMILES CCc1c(cnn1-c1ccc(cc1)C#N)C(=O)N1CCc2cc3ccnc(N4CCN(C)CC4)c3cc12 Show InChI InChI=1S/C29H29N7O/c1-3-26-25(19-32-36(26)23-6-4-20(18-30)5-7-23)29(37)35-11-9-22-16-21-8-10-31-28(24(21)17-27(22)35)34-14-12-33(2)13-15-34/h4-8,10,16-17,19H,3,9,11-15H2,1-2H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410432 (CHEMBL197947) Show SMILES CCc1c(cnn1-c1ccc(cc1)C#N)C(=O)N1CCc2cc3ccnc(N4CCN5CCC[C@@H]5C4)c3cc12 Show InChI InChI=1S/C31H31N7O/c1-2-28-27(19-34-38(28)24-7-5-21(18-32)6-8-24)31(39)37-13-10-23-16-22-9-11-33-30(26(22)17-29(23)37)36-15-14-35-12-3-4-25(35)20-36/h5-9,11,16-17,19,25H,2-4,10,12-15,20H2,1H3/t25-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474396 (CHEMBL2113356) Show SMILES Cl.COc1ccc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OS(C)(=O)=O)cc4CC3)CC2)cc1 |r,wU:12.10,wD:15.14,(24.07,.02,;21.35,-2.37,;20.73,-1.3,;19.19,-1.3,;18.42,.03,;16.88,.03,;16.11,-1.31,;14.57,-1.31,;13.8,.03,;12.26,.02,;11.64,-1.04,;11.49,1.36,;9.95,1.36,;9.18,.02,;7.64,.02,;6.87,1.35,;5.33,1.34,;4.56,.01,;3.02,,;2.31,1.43,;.8,1.73,;,.78,;-1.53,1.57,;-2.91,.78,;-2.91,-.78,;-4.24,-1.55,;-5.58,-.78,;-6.64,-.16,;-6.64,-1.39,;-5.57,.45,;-1.53,-1.57,;,-.78,;.76,-1.7,;2.29,-1.45,;7.63,2.69,;9.17,2.69,;16.89,-2.64,;18.43,-2.64,)| Show InChI InChI=1S/C29H38N2O5S.ClH/c1-35-27-11-5-22(6-12-27)7-14-29(32)30-26-9-3-23(4-10-26)15-18-31-19-16-24-8-13-28(36-37(2,33)34)21-25(24)17-20-31;/h5-8,11-14,21,23,26H,3-4,9-10,15-20H2,1-2H3,(H,30,32);1H/b14-7+;/t23-,26-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410429 (CHEMBL194809) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4ccccc4Cl)c3cc12 Show InChI InChI=1S/C23H23ClN4O/c1-26-10-12-27(13-11-26)22-19-15-21-17(14-16(19)6-8-25-22)7-9-28(21)23(29)18-4-2-3-5-20(18)24/h2-6,8,14-15H,7,9-13H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.26	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1A (Homo sapiens (Human))	BDBM50410436 (CHEMBL382078) Show SMILES CCc1c(cnn1-c1ccc(cc1)C#N)C(=O)N1CCc2cc3ccnc(N4CCN5CCC[C@H]5C4)c3cc12 Show InChI InChI=1S/C31H31N7O/c1-2-28-27(19-34-38(28)24-7-5-21(18-32)6-8-24)31(39)37-13-10-23-16-22-9-11-33-30(26(22)17-29(23)37)36-15-14-35-12-3-4-25(35)20-36/h5-9,11,16-17,19,25H,2-4,10,12-15,20H2,1H3/t25-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.26	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-5-HT or [3H]8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1A (Homo sapiens (Human))	BDBM50410434 (CHEMBL372651) Show SMILES CCc1c(cnn1-c1ccc(cc1)C#N)C(=O)N1CCc2cc3ccnc(N4CCNCC4)c3cc12 Show InChI InChI=1S/C28H27N7O/c1-2-25-24(18-32-35(25)22-5-3-19(17-29)4-6-22)28(36)34-12-8-21-15-20-7-9-31-27(23(20)16-26(21)34)33-13-10-30-11-14-33/h3-7,9,15-16,18,30H,2,8,10-14H2,1H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.26	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-5-HT or [3H]8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1A (Homo sapiens (Human))	BDBM50410430 (CHEMBL372743) Show SMILES CCc1c(cnn1-c1ccc(cc1)C#N)C(=O)N1CCc2cc3ccnc(N4CCN(C)CC4)c3cc12 Show InChI InChI=1S/C29H29N7O/c1-3-26-25(19-32-36(26)23-6-4-20(18-30)5-7-23)29(37)35-11-9-22-16-21-8-10-31-28(24(21)17-27(22)35)34-14-12-33(2)13-15-34/h4-8,10,16-17,19H,3,9,11-15H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.26	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-5-HT or [3H]8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1D (Homo sapiens (Human))	BDBM50410428 (CHEMBL380812) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4cnn5ccccc45)c3cc12 Show InChI InChI=1S/C24H24N6O/c1-27-10-12-28(13-11-27)23-19-15-22-18(14-17(19)5-7-25-23)6-9-29(22)24(31)20-16-26-30-8-3-2-4-21(20)30/h2-5,7-8,14-16H,6,9-13H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	1.26	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474403 (CHEMBL2368633) Show SMILES Cl.COc1ccccc1\C=C\C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(OS(C)(=O)=O)cc3CC2)CC1 |r,wU:17.17,wD:14.13,(17.12,,;8.32,.14,;9.86,.14,;10.63,-1.19,;12.17,-1.19,;12.94,-2.53,;12.17,-3.86,;10.63,-3.86,;9.86,-2.53,;8.32,-2.53,;7.55,-1.19,;6.01,-1.19,;5.24,-2.53,;5.24,.14,;3.7,.14,;2.93,1.47,;1.39,1.47,;.62,.14,;-.92,.14,;-1.69,1.47,;-3.23,1.47,;-3.9,2.86,;-5.4,3.2,;-6.61,2.24,;-7.94,3.01,;-9.27,2.24,;-9.27,.7,;-10.61,-.07,;-11.94,.7,;-11.17,2.04,;-13.28,1.47,;-12.71,-.63,;-7.94,-.07,;-6.61,.7,;-5.4,-.26,;-3.9,.09,;1.39,-1.19,;2.93,-1.19,)| Show InChI InChI=1S/C29H38N2O5S.ClH/c1-35-28-6-4-3-5-24(28)10-14-29(32)30-26-11-7-22(8-12-26)15-18-31-19-16-23-9-13-27(36-37(2,33)34)21-25(23)17-20-31;/h3-6,9-10,13-14,21-22,26H,7-8,11-12,15-20H2,1-2H3,(H,30,32);1H/b14-10+;/t22-,26-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474395 (CHEMBL2368626) Show SMILES Cl.CS(=O)(=O)c1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)\C=C\c3ccccc3F)CCc2c1 |r,wU:14.12,wD:17.19,(16.9,,;-11.6,1.4,;-10.83,.07,;-12.16,-.7,;-10.06,-1.27,;-9.49,.84,;-9.49,2.38,;-8.16,3.15,;-6.83,2.38,;-5.62,3.34,;-4.12,3,;-3.45,1.61,;-1.91,1.61,;-1.14,.27,;.4,.27,;1.17,1.61,;2.71,1.61,;3.48,.27,;2.71,-1.06,;1.17,-1.06,;5.02,.27,;5.79,-1.06,;5.02,-2.39,;7.33,-1.06,;8.1,-2.39,;9.64,-2.39,;10.41,-3.73,;11.95,-3.73,;12.72,-2.39,;11.95,-1.06,;10.41,-1.06,;9.64,.27,;-4.12,.22,;-5.62,-.12,;-6.83,.84,;-8.16,.07,)| Show InChI InChI=1S/C28H35FN2O3S.ClH/c1-35(33,34)26-12-8-22-15-18-31(19-16-24(22)20-26)17-14-21-6-10-25(11-7-21)30-28(32)13-9-23-4-2-3-5-27(23)29;/h2-5,8-9,12-13,20-21,25H,6-7,10-11,14-19H2,1H3,(H,30,32);1H/b13-9+;/t21-,25-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474389 (CHEMBL3084597) Show SMILES Cl.Cc1ncc(o1)-c1cccc(c1)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(OS(C)(=O)=O)cc3CC2)CC1 |r,wU:16.16,wD:19.20,(17.49,,;13.31,-5.65,;11.9,-5.02,;10.57,-5.79,;9.43,-4.76,;10.05,-3.36,;11.58,-3.52,;9.28,-2.02,;10.05,-.69,;9.28,.64,;7.74,.64,;6.97,-.69,;7.74,-2.02,;5.43,-.69,;4.66,-2.02,;4.66,.64,;3.12,.64,;2.35,-.69,;.81,-.69,;.04,.64,;-1.5,.64,;-2.27,1.98,;-3.81,1.98,;-4.48,3.37,;-5.98,3.71,;-7.18,2.75,;-8.52,3.52,;-9.85,2.75,;-9.85,1.21,;-11.18,.44,;-12.52,1.21,;-11.75,2.54,;-13.85,1.98,;-13.29,-.13,;-8.52,.44,;-7.18,1.21,;-5.98,.25,;-4.48,.59,;.81,1.98,;2.35,1.98,)| Show InChI InChI=1S/C30H37N3O5S.ClH/c1-21-31-20-29(37-21)25-4-3-5-26(18-25)30(34)32-27-9-6-22(7-10-27)12-15-33-16-13-23-8-11-28(38-39(2,35)36)19-24(23)14-17-33;/h3-5,8,11,18-20,22,27H,6-7,9-10,12-17H2,1-2H3,(H,32,34);1H/t22-,27-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474399 (CHEMBL2368625) Show SMILES Cl.CS(=O)(=O)Oc1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)\C=C\c3ccccc3F)CCc2c1 |r,wU:15.13,wD:18.20,(17.35,,;-10.94,2.04,;-11.71,.71,;-13.05,1.48,;-12.48,-.63,;-10.38,-.06,;-9.04,.71,;-9.04,2.25,;-7.71,3.02,;-6.38,2.25,;-5.17,3.21,;-3.67,2.87,;-3,1.48,;-1.46,1.48,;-.69,.14,;.85,.14,;1.62,1.48,;3.16,1.48,;3.93,.14,;3.16,-1.19,;1.62,-1.19,;5.47,.14,;6.24,-1.19,;5.47,-2.52,;7.78,-1.19,;8.55,-2.52,;10.09,-2.52,;10.86,-3.86,;12.4,-3.86,;13.17,-2.52,;12.4,-1.19,;10.86,-1.19,;10.09,.14,;-3.67,.09,;-5.17,-.25,;-6.38,.71,;-7.71,-.06,)| Show InChI InChI=1S/C28H35FN2O4S.ClH/c1-36(33,34)35-26-12-8-22-15-18-31(19-16-24(22)20-26)17-14-21-6-10-25(11-7-21)30-28(32)13-9-23-4-2-3-5-27(23)29;/h2-5,8-9,12-13,20-21,25H,6-7,10-11,14-19H2,1H3,(H,30,32);1H/b13-9+;/t21-,25-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474406 (CHEMBL3084598) Show SMILES Cl.Cc1ccc2c(cccc2n1)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(OS(C)(=O)=O)cc3CC2)CC1 |r,wU:15.15,wD:18.19,(14.83,,;10.65,-6.18,;9.88,-4.85,;8.34,-4.85,;7.57,-3.51,;8.34,-2.18,;7.57,-.85,;8.34,.49,;9.88,.49,;10.65,-.85,;9.88,-2.18,;10.65,-3.51,;6.03,-.85,;5.26,-2.18,;5.26,.49,;3.72,.49,;2.95,-.85,;1.41,-.85,;.64,.49,;-.9,.49,;-1.67,1.82,;-3.21,1.82,;-3.88,3.21,;-5.38,3.55,;-6.58,2.59,;-7.92,3.36,;-9.25,2.59,;-9.25,1.05,;-10.58,.28,;-11.92,1.05,;-11.15,2.38,;-13.25,1.82,;-12.69,-.28,;-7.92,.28,;-6.58,1.05,;-5.38,.09,;-3.88,.43,;1.41,1.82,;2.95,1.82,)| Show InChI InChI=1S/C30H37N3O4S.ClH/c1-21-6-13-27-28(4-3-5-29(27)31-21)30(34)32-25-10-7-22(8-11-25)14-17-33-18-15-23-9-12-26(37-38(2,35)36)20-24(23)16-19-33;/h3-6,9,12-13,20,22,25H,7-8,10-11,14-19H2,1-2H3,(H,32,34);1H/t22-,25-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474412 (CHEMBL2368622) Show SMILES Cl.CS(=O)(=O)Oc1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)\C=C\c3cccc(F)c3)CCc2c1 |r,wU:18.20,wD:15.13,(17.26,,;-11.03,.56,;-11.8,-.77,;-13.13,-0,;-12.57,-2.11,;-10.46,-1.54,;-9.13,-.77,;-9.13,.77,;-7.8,1.54,;-6.46,.77,;-5.26,1.73,;-3.76,1.38,;-3.09,-0,;-1.55,-0,;-.78,-1.34,;.76,-1.34,;1.53,-2.67,;3.07,-2.67,;3.84,-1.34,;3.07,-0,;1.53,-0,;5.38,-1.34,;6.15,-0,;5.38,1.33,;7.69,-0,;8.46,1.33,;10,1.33,;10.77,-0,;12.31,-0,;13.08,1.33,;12.31,2.66,;13.08,4,;10.77,2.66,;-3.76,-1.39,;-5.26,-1.73,;-6.46,-.77,;-7.8,-1.54,)| Show InChI InChI=1S/C28H35FN2O4S.ClH/c1-36(33,34)35-27-11-8-23-14-17-31(18-15-24(23)20-27)16-13-21-5-9-26(10-6-21)30-28(32)12-7-22-3-2-4-25(29)19-22;/h2-4,7-8,11-12,19-21,26H,5-6,9-10,13-18H2,1H3,(H,30,32);1H/b12-7+;/t21-,26-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1A (Homo sapiens (Human))	BDBM50410432 (CHEMBL197947) Show SMILES CCc1c(cnn1-c1ccc(cc1)C#N)C(=O)N1CCc2cc3ccnc(N4CCN5CCC[C@@H]5C4)c3cc12 Show InChI InChI=1S/C31H31N7O/c1-2-28-27(19-34-38(28)24-7-5-21(18-32)6-8-24)31(39)37-13-10-23-16-22-9-11-33-30(26(22)17-29(23)37)36-15-14-35-12-3-4-25(35)20-36/h5-9,11,16-17,19,25H,2-4,10,12-15,20H2,1H3/t25-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.58	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-5-HT or [3H]8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410433 (CHEMBL426285) Show SMILES CCN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4cnn(c4CC)-c4ccc(cc4)C#N)c3cc12 Show InChI InChI=1S/C30H31N7O/c1-3-27-26(20-33-37(27)24-7-5-21(19-31)6-8-24)30(38)36-12-10-23-17-22-9-11-32-29(25(22)18-28(23)36)35-15-13-34(4-2)14-16-35/h5-9,11,17-18,20H,3-4,10,12-16H2,1-2H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.58	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474410 (CHEMBL2368620) Show SMILES Cl.CS(=O)(=O)c1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)\C=C\c3ccccc3C#N)CCc2c1 |r,wU:14.12,wD:17.19,(21.76,-1.31,;-5.31,-2.17,;-4.24,-1.55,;-4.24,-2.79,;-5.31,-.94,;-2.91,-.78,;-2.91,.78,;-1.53,1.57,;,.78,;.8,1.73,;2.31,1.43,;3.02,,;4.56,.01,;5.33,1.34,;6.87,1.35,;7.63,2.69,;9.17,2.69,;9.95,1.36,;9.18,.02,;7.64,.02,;11.49,1.36,;12.26,.02,;11.64,-1.04,;13.8,.03,;14.57,-1.31,;16.11,-1.31,;16.88,.03,;18.42,.03,;19.19,-1.3,;18.43,-2.64,;16.89,-2.64,;16.12,-3.98,;15.5,-5.04,;2.29,-1.45,;.76,-1.7,;,-.78,;-1.53,-1.57,)| Show InChI InChI=1S/C29H35N3O3S.ClH/c1-36(34,35)28-12-8-24-15-18-32(19-16-25(24)20-28)17-14-22-6-10-27(11-7-22)31-29(33)13-9-23-4-2-3-5-26(23)21-30;/h2-5,8-9,12-13,20,22,27H,6-7,10-11,14-19H2,1H3,(H,31,33);1H/b13-9+;/t22-,27-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50000022 (CHEMBL57219) Show SMILES CCCN(CCCCNC(=O)c1ccc(cc1)-c1ccccc1)C1CCc2c(C1)cccc2OS(=O)(=O)C(F)(F)F Show InChI InChI=1S/C31H35F3N2O4S/c1-2-20-36(27-17-18-28-26(22-27)11-8-12-29(28)40-41(38,39)31(32,33)34)21-7-6-19-35-30(37)25-15-13-24(14-16-25)23-9-4-3-5-10-23/h3-5,8-16,27H,2,6-7,17-22H2,1H3,(H,35,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	1.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
SmithKline Beecham Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells				Bioorg Med Chem Lett 9: 179-84 (1999) BindingDB Entry DOI: 10.7270/Q2057J4D
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50000027 (CHEMBL51977) Show SMILES CCCN(CCCCNC(=O)c1ccc(cc1)-c1ccccc1)C1CCc2c(Cl)cccc2C1 Show InChI InChI=1S/C30H35ClN2O/c1-2-20-33(27-17-18-28-26(22-27)11-8-12-29(28)31)21-7-6-19-32-30(34)25-15-13-24(14-16-25)23-9-4-3-5-10-23/h3-5,8-16,27H,2,6-7,17-22H2,1H3,(H,32,34)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	1.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
SmithKline Beecham Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells				Bioorg Med Chem Lett 9: 179-84 (1999) BindingDB Entry DOI: 10.7270/Q2057J4D
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474393 (CHEMBL2368623) Show SMILES Cl.CS(=O)(=O)c1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)\C=C\c3cccc(F)c3)CCc2c1 |r,wU:17.19,wD:14.12,(16.81,,;-11.68,-.12,;-10.91,-1.46,;-12.25,-2.23,;-10.14,-2.79,;-9.58,-.69,;-9.58,.85,;-8.25,1.62,;-6.91,.85,;-5.71,1.81,;-4.21,1.47,;-3.54,.08,;-2,.08,;-1.23,-1.25,;.31,-1.25,;1.08,-2.58,;2.62,-2.58,;3.39,-1.25,;2.62,.08,;1.08,.08,;4.93,-1.25,;5.7,.08,;4.93,1.42,;7.24,.08,;8.01,1.42,;9.55,1.42,;10.32,.08,;11.86,.08,;12.63,1.42,;11.86,2.75,;12.63,4.08,;10.32,2.75,;-4.21,-1.3,;-5.71,-1.65,;-6.91,-.69,;-8.25,-1.46,)| Show InChI InChI=1S/C28H35FN2O3S.ClH/c1-35(33,34)27-11-8-23-14-17-31(18-15-24(23)20-27)16-13-21-5-9-26(10-6-21)30-28(32)12-7-22-3-2-4-25(29)19-22;/h2-4,7-8,11-12,19-21,26H,5-6,9-10,13-18H2,1H3,(H,30,32);1H/b12-7+;/t21-,26-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50217172 (CHEMBL52724) Show SMILES CNC(=O)c1cccc(c1)-c1ccc(cc1)C(=O)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1 Show InChI InChI=1S/C29H30F3N3O5S/c1-33-27(36)24-6-4-5-23(17-24)20-7-9-22(10-8-20)28(37)34-14-2-3-15-35-16-13-21-11-12-26(18-25(21)19-35)40-41(38,39)29(30,31)32/h4-12,17-18H,2-3,13-16,19H2,1H3,(H,33,36)(H,34,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
SmithKline Beecham Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells				Bioorg Med Chem Lett 9: 179-84 (1999) BindingDB Entry DOI: 10.7270/Q2057J4D
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474392 (CHEMBL3084601) Show SMILES Cl.CS(=O)(=O)Oc1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)c3cccc(c3)-c3ncccn3)CCc2c1 |r,wU:18.20,wD:15.13,(16.59,,;-11.7,.29,;-12.47,-1.05,;-13.8,-.28,;-13.24,-2.38,;-11.13,-1.82,;-9.8,-1.05,;-9.8,.49,;-8.47,1.26,;-7.13,.49,;-5.93,1.45,;-4.43,1.11,;-3.76,-.28,;-2.22,-.28,;-1.45,-1.61,;.09,-1.61,;.86,-2.94,;2.4,-2.94,;3.17,-1.61,;2.4,-.28,;.86,-.28,;4.71,-1.61,;5.48,-.28,;4.71,1.06,;7.02,-.28,;7.79,-1.61,;9.33,-1.61,;10.1,-.28,;9.33,1.06,;7.79,1.06,;10.1,2.39,;9.33,3.72,;10.1,5.06,;11.64,5.06,;12.41,3.72,;11.64,2.39,;-4.43,-1.66,;-5.93,-2.01,;-7.13,-1.05,;-8.47,-1.82,)| Show InChI InChI=1S/C30H36N4O4S.ClH/c1-39(36,37)38-28-11-8-23-13-18-34(19-14-24(23)21-28)17-12-22-6-9-27(10-7-22)33-30(35)26-5-2-4-25(20-26)29-31-15-3-16-32-29;/h2-5,8,11,15-16,20-22,27H,6-7,9-10,12-14,17-19H2,1H3,(H,33,35);1H/t22-,27-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1D (Homo sapiens (Human))	BDBM50410435 (CHEMBL191971 | SB-272183) Show SMILES CN1CCN(CC1)c1cc2N(CCc2cc1Cl)C(=O)Nc1ccc(-c2ccncc2)c2ccccc12 Show InChI InChI=1S/C29H28ClN5O/c1-33-14-16-34(17-15-33)28-19-27-21(18-25(28)30)10-13-35(27)29(36)32-26-7-6-22(20-8-11-31-12-9-20)23-4-2-3-5-24(23)26/h2-9,11-12,18-19H,10,13-17H2,1H3,(H,32,36)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474407 (CHEMBL2368624) Show SMILES Cl.CS(=O)(=O)c1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)\C=C\c3cccc(c3)C#N)CCc2c1 |r,wU:17.19,wD:14.12,(22.54,-1.31,;-5.31,-2.17,;-4.24,-1.55,;-4.24,-2.79,;-5.31,-.94,;-2.91,-.78,;-2.91,.78,;-1.53,1.57,;,.78,;.8,1.73,;2.31,1.43,;3.02,,;4.56,.01,;5.33,1.34,;6.87,1.35,;7.64,.02,;9.18,.02,;9.95,1.36,;9.17,2.69,;7.63,2.69,;11.49,1.36,;12.26,.02,;11.64,-1.04,;13.8,.03,;14.57,-1.31,;16.11,-1.31,;16.88,.03,;18.42,.03,;19.19,-1.3,;18.43,-2.64,;16.89,-2.64,;19.2,-3.97,;19.82,-5.03,;2.29,-1.45,;.76,-1.7,;,-.78,;-1.53,-1.57,)| Show InChI InChI=1S/C29H35N3O3S.ClH/c1-36(34,35)28-11-8-25-14-17-32(18-15-26(25)20-28)16-13-22-5-9-27(10-6-22)31-29(33)12-7-23-3-2-4-24(19-23)21-30;/h2-4,7-8,11-12,19-20,22,27H,5-6,9-10,13-18H2,1H3,(H,31,33);1H/b12-7+;/t22-,27-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474404 (CHEMBL2368627) Show SMILES Cl.CS(=O)(=O)c1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)\C=C\c3cc(F)cc(F)c3)CCc2c1 |r,wU:17.19,wD:14.12,(16.46,,;-12.04,-.09,;-11.27,-1.42,;-12.6,-2.19,;-10.5,-2.76,;-9.93,-.65,;-9.93,.89,;-8.6,1.66,;-7.26,.89,;-6.06,1.85,;-4.56,1.51,;-3.89,.12,;-2.35,.12,;-1.58,-1.22,;-.04,-1.22,;.73,-2.55,;2.27,-2.55,;3.04,-1.22,;2.27,.12,;.73,.12,;4.58,-1.22,;5.35,.12,;4.58,1.45,;6.89,.12,;7.66,1.45,;9.2,1.45,;9.97,2.79,;11.51,2.79,;12.28,4.12,;12.28,1.45,;11.51,.12,;12.28,-1.22,;9.97,.12,;-4.56,-1.27,;-6.06,-1.61,;-7.26,-.65,;-8.6,-1.42,)| Show InChI InChI=1S/C28H34F2N2O3S.ClH/c1-36(34,35)27-8-5-22-11-14-32(15-12-23(22)18-27)13-10-20-2-6-26(7-3-20)31-28(33)9-4-21-16-24(29)19-25(30)17-21;/h4-5,8-9,16-20,26H,2-3,6-7,10-15H2,1H3,(H,31,33);1H/b9-4+;/t20-,26-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410436 (CHEMBL382078) Show SMILES CCc1c(cnn1-c1ccc(cc1)C#N)C(=O)N1CCc2cc3ccnc(N4CCN5CCC[C@H]5C4)c3cc12 Show InChI InChI=1S/C31H31N7O/c1-2-28-27(19-34-38(28)24-7-5-21(18-32)6-8-24)31(39)37-13-10-23-16-22-9-11-33-30(26(22)17-29(23)37)36-15-14-35-12-3-4-25(35)20-36/h5-9,11,16-17,19,25H,2-4,10,12-15,20H2,1H3/t25-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474401 (CHEMBL2368618) Show SMILES Cl.COc1cccc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OS(C)(=O)=O)cc4CC3)CC2)c1 |r,wU:16.15,wD:13.11,(16.93,,;11.98,5.19,;12.75,3.85,;11.98,2.52,;12.75,1.19,;11.98,-.15,;10.44,-.15,;9.67,1.19,;8.13,1.19,;7.36,-.15,;5.82,-.15,;5.05,1.19,;5.05,-1.48,;3.51,-1.48,;2.74,-.15,;1.2,-.15,;.43,-1.48,;-1.11,-1.48,;-1.88,-.15,;-3.42,-.15,;-4.09,1.24,;-5.59,1.58,;-6.79,.62,;-8.13,1.39,;-9.46,.62,;-9.46,-.92,;-10.8,-1.69,;-12.13,-.92,;-11.36,.42,;-13.46,-.15,;-12.9,-2.25,;-8.13,-1.69,;-6.79,-.92,;-5.59,-1.88,;-4.09,-1.54,;1.2,-2.82,;2.74,-2.82,;10.44,2.52,)| Show InChI InChI=1S/C29H38N2O5S.ClH/c1-35-27-5-3-4-23(20-27)8-13-29(32)30-26-10-6-22(7-11-26)14-17-31-18-15-24-9-12-28(36-37(2,33)34)21-25(24)16-19-31;/h3-5,8-9,12-13,20-22,26H,6-7,10-11,14-19H2,1-2H3,(H,30,32);1H/b13-8+;/t22-,26-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474413 (CHEMBL3084626) Show SMILES Cl.Cc1cc(on1)-c1cccc(c1)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(OS(C)(=O)=O)cc3CC2)CC1 |r,wU:16.16,wD:19.20,(16.16,,;10.48,-7.28,;10.64,-5.75,;9.5,-4.72,;10.13,-3.31,;11.66,-3.47,;11.98,-4.98,;9.36,-1.98,;10.13,-.65,;9.36,.69,;7.82,.69,;7.05,-.65,;7.82,-1.98,;5.51,-.65,;4.74,-1.98,;4.74,.69,;3.2,.69,;2.43,-.65,;.89,-.65,;.12,.69,;-1.42,.69,;-2.19,2.02,;-3.73,2.02,;-4.4,3.41,;-5.9,3.75,;-7.11,2.79,;-8.44,3.56,;-9.77,2.79,;-9.77,1.25,;-11.11,.48,;-12.44,1.25,;-11.67,2.59,;-13.78,2.02,;-13.21,-.08,;-8.44,.48,;-7.11,1.25,;-5.9,.29,;-4.4,.63,;.89,2.02,;2.43,2.02,)| Show InChI InChI=1S/C30H37N3O5S.ClH/c1-21-18-29(37-32-21)25-4-3-5-26(19-25)30(34)31-27-9-6-22(7-10-27)12-15-33-16-13-23-8-11-28(38-39(2,35)36)20-24(23)14-17-33;/h3-5,8,11,18-20,22,27H,6-7,9-10,12-17H2,1-2H3,(H,31,34);1H/t22-,27-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50217155 (CHEMBL291545) Show SMILES FC(F)(F)S(=O)(=O)Oc1ccc2CCN(CCCCNC(=O)\C=C\c3ccc4[nH]ccc4c3)Cc2c1 Show InChI InChI=1S/C25H26F3N3O4S/c26-25(27,28)36(33,34)35-22-6-5-19-10-14-31(17-21(19)16-22)13-2-1-11-30-24(32)8-4-18-3-7-23-20(15-18)9-12-29-23/h3-9,12,15-16,29H,1-2,10-11,13-14,17H2,(H,30,32)/b8-4+	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
SmithKline Beecham Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells				Bioorg Med Chem Lett 9: 179-84 (1999) BindingDB Entry DOI: 10.7270/Q2057J4D
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474414 (CHEMBL2368617) Show SMILES Cl.CS(=O)(=O)c1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)\C=C\c3ccc(cc3)C#N)CCc2c1 |r,wU:17.19,wD:14.12,(19.41,,;-10.62,-4.24,;-11.39,-2.9,;-12.73,-3.67,;-12.16,-1.57,;-10.06,-2.13,;-10.06,-.59,;-8.73,.18,;-7.39,-.59,;-6.19,.37,;-4.69,.02,;-4.02,-1.36,;-2.48,-1.36,;-1.71,-.03,;-.17,-.03,;.6,-1.36,;2.14,-1.36,;2.91,-.03,;2.14,1.3,;.6,1.3,;4.45,-.03,;5.22,1.3,;4.45,2.64,;6.76,1.3,;7.53,2.64,;9.07,2.64,;9.84,3.97,;11.38,3.97,;12.15,2.64,;11.38,1.3,;9.84,1.3,;13.69,2.64,;15.23,2.64,;-4.69,-2.75,;-6.19,-3.09,;-7.39,-2.13,;-8.73,-2.9,)| Show InChI InChI=1S/C29H35N3O3S.ClH/c1-36(34,35)28-12-9-25-15-18-32(19-16-26(25)20-28)17-14-23-6-10-27(11-7-23)31-29(33)13-8-22-2-4-24(21-30)5-3-22;/h2-5,8-9,12-13,20,23,27H,6-7,10-11,14-19H2,1H3,(H,31,33);1H/b13-8+;/t23-,27-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 1B (Homo sapiens (Human))	BDBM50410439 (CHEMBL199175) Show SMILES CN1CCN(CC1)c1nccc2cc3CCN(C(=O)c4cc(C)oc4C(F)(F)F)c3cc12 Show InChI InChI=1S/C23H23F3N4O2/c1-14-11-18(20(32-14)23(24,25)26)22(31)30-6-4-16-12-15-3-5-27-21(17(15)13-19(16)30)29-9-7-28(2)8-10-29/h3,5,11-13H,4,6-10H2,1-2H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Mean binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT or [3H]-8-OH-DPAT as the radioligand				Bioorg Med Chem Lett 15: 4370-4 (2005) Article DOI: 10.1016/j.bmcl.2005.06.042 BindingDB Entry DOI: 10.7270/Q2319X3T
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50474388 (CHEMBL3084625) Show SMILES Cl.CS(=O)(=O)Oc1ccc2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)c3cccc4ncccc34)CCc2c1 |r,wU:15.13,wD:18.20,(9.19,,;-2.22,-10.86,;-.88,-11.63,;-1.65,-12.96,;.45,-12.4,;-.11,-10.3,;-.88,-8.96,;-2.42,-8.96,;-3.19,-7.63,;-2.42,-6.3,;-3.38,-5.09,;-3.04,-3.59,;-1.65,-2.92,;-1.65,-1.38,;-.32,-.61,;-.32,.93,;-1.65,1.7,;-1.65,3.24,;-.32,4.01,;1.01,3.24,;1.01,1.7,;-.32,5.55,;1.01,6.32,;2.35,5.55,;1.01,7.86,;-.32,8.63,;-.32,10.17,;1.01,10.94,;2.35,10.17,;3.68,10.94,;5.01,10.17,;5.01,8.63,;3.68,7.86,;2.35,8.63,;-.27,-3.59,;.08,-5.09,;-.88,-6.3,;-.11,-7.63,)| Show InChI InChI=1S/C29H35N3O4S.ClH/c1-37(34,35)36-25-12-9-22-14-18-32(19-15-23(22)20-25)17-13-21-7-10-24(11-8-21)31-29(33)27-4-2-6-28-26(27)5-3-16-30-28;/h2-6,9,12,16,20-21,24H,7-8,10-11,13-15,17-19H2,1H3,(H,31,33);1H/t21-,24-;	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity against human Dopamine receptor D3 expressed in CHO cells by using [125I]iodosulpiride as radioligand				J Med Chem 46: 4952-64 (2003) Article DOI: 10.1021/jm030817d BindingDB Entry DOI: 10.7270/Q2TT4TPR
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 309 total )  |  Next  |  Last  >>

Jump to: